(Q39986347)

16 September 2017

1 reference

title

Hemodynamic and vascular responses to antihypertensive treatment with adrenergic blocking agents: A review (English)

1 reference

https://api.crossref.org/works/10.1016/0002-8703(70)90402-3

17 March 2023

1 reference

Cardiology and cardiovascular medicine

1 reference

https://api.crossref.org/works/10.1016/0002-8703(70)90402-3

17 March 2023

author name string

R. Sannerstedt

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4903136

17 March 2023

J. Conway

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4903136

17 March 2023

language of work or name

English

0 references

publication date

1 January 1970

1 reference

full work available at URL

16 September 2017

https://api.elsevier.com/content/article/PII:0002870370904023?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-8703(70)90402-3

https://api.elsevier.com/content/article/PII:0002870370904023?httpAccept=text/plain

17 March 2023

1 reference

https://api.crossref.org/works/10.1016/0002-8703(70)90402-3

17 March 2023

published in

American Heart Journal

1 reference

16 September 2017

79

1 reference

16 September 2017

122-127

1 reference

16 September 2017

1

1 reference

Influence of Hypertension on the Hemodynamic Response to Exercise

16 September 2017

2

1 reference

https://api.crossref.org/works/10.1016/0002-8703(70)90402-3

Effects of reserpine on the circulation and on the circulatory responses to tilting and norepinephrine

17 March 2023

4

1 reference

https://api.crossref.org/works/10.1016/0002-8703(70)90402-3

Cardiovascular and renal hemodynamic response to reserpine (serpasil), and clinical results of using this agent for the treatment of hypertension

17 March 2023

6

1 reference

https://api.crossref.org/works/10.1016/0002-8703(70)90402-3

Some cardiovascular effects of reserpine

17 March 2023

7

1 reference

https://api.crossref.org/works/10.1016/0002-8703(70)90402-3

Clinical and experimental effects of reserpine in patients with essential hypertension

17 March 2023

8

1 reference

https://api.crossref.org/works/10.1016/0002-8703(70)90402-3

Influence of syrosingopine on the cardiovascular response to acute hypoxemia and exercise

17 March 2023

9

1 reference

https://api.crossref.org/works/10.1016/0002-8703(70)90402-3

Hemodynamic aspects of modern medical treatment of arterial hypertension

17 March 2023

10

1 reference

https://api.crossref.org/works/10.1016/0002-8703(70)90402-3

Pressor responses to noxious stimuli in hypertensive patients. Effects of reserpine and chlorothiazide

17 March 2023

11

1 reference

https://api.crossref.org/works/10.1016/0002-8703(70)90402-3

The cardiorenal hemodynamic effects of antihypertensive therapy with reserpine

17 March 2023

12

1 reference

https://api.crossref.org/works/10.1016/0002-8703(70)90402-3

EFFECTS OF GUANETHIDINE, RESERPINE, AND METHYLDOPA ON REFLEX VENOUS AND ARTERIAL CONSTRICTION IN MAN.

17 March 2023

14

1 reference

https://api.crossref.org/works/10.1016/0002-8703(70)90402-3

Reserpine and extracellular-fluid volume

17 March 2023

15

1 reference

https://api.crossref.org/works/10.1016/0002-8703(70)90402-3

The effect of reserpine on the electrolyte and fluid balance in man

17 March 2023

16

1 reference

https://api.crossref.org/works/10.1016/0002-8703(70)90402-3

Circulatory and respiratory effects of guanethidin

17 March 2023

18

1 reference

https://api.crossref.org/works/10.1016/0002-8703(70)90402-3

The effects of intravenous guanethidine on the systemic and pulmonary circulations in man

17 March 2023

19

1 reference

https://api.crossref.org/works/10.1016/0002-8703(70)90402-3

Hemodynamic Effects of Guanethidine in Man

17 March 2023

20

1 reference

https://api.crossref.org/works/10.1016/0002-8703(70)90402-3

EFFECTS OF GUANETHIDINE ON RENAL FUNCTION

17 March 2023

21

1 reference

https://api.crossref.org/works/10.1016/0002-8703(70)90402-3

EFFECT OF GUANETHIDINE AND BRETYLIUM TOSYLATE ON SYSTEMIC AND RENAL HEMODYNAMICS IN ESSENTIAL HYPERTENSION

17 March 2023

22

1 reference

https://api.crossref.org/works/10.1016/0002-8703(70)90402-3

HEMODYNAMIC RESPONSE TO ANTIHYPERTENSIVE DRUG THERAPY

17 March 2023

23

1 reference

https://api.crossref.org/works/10.1016/0002-8703(70)90402-3

Human pharmacology of guanethidine

17 March 2023

26

1 reference

https://api.crossref.org/works/10.1016/0002-8703(70)90402-3

PRESSOR RESPONSES TO NOXIOUS STIMULI IN HYPERTENSIVE PATIENTS: EFFECTS OF GUANETHIDINE SULFATE AND ALPHA METHYLDOPA

17 March 2023

27

1 reference

https://api.crossref.org/works/10.1016/0002-8703(70)90402-3

THE EFFECTS OF GUANETHIDINE AND OF ALPHA-METHYLDOPA ON THE DIGITAL CIRCULATION IN HYPERTENSION.

17 March 2023

28

1 reference

https://api.crossref.org/works/10.1016/0002-8703(70)90402-3

GUANETHIDINE AND METHYLDOPA: A HAeMODYNAMIC STUDY

17 March 2023

29

1 reference

https://api.crossref.org/works/10.1016/0002-8703(70)90402-3

Haemodynamic effects of guanethidine

17 March 2023

30

1 reference

https://api.crossref.org/works/10.1016/0002-8703(70)90402-3

THE EFFECTS OF AUTONOMIC NERVOUS SYSTEM INHIBITION ON THE CIRCULATORY RESPONSE TO MUSCULAR EXERCISE.

17 March 2023

31

1 reference

https://api.crossref.org/works/10.1016/0002-8703(70)90402-3

[The effect of prolonged guanethidine administration on the kidney function of hypertensive patients.]

17 March 2023

32

1 reference

https://api.crossref.org/works/10.1016/0002-8703(70)90402-3

BLOOD-VOLUME DURING TREATMENT OF HYPERTENSION WITH GUANETHIDINE

17 March 2023

33

1 reference

https://api.crossref.org/works/10.1016/0002-8703(70)90402-3

FLUID RETENTION PRODUCED BY GUANETHIDINE; CHANGES IN BODY EXCHANGEABLE SODIUM, BLOOD VOLUME, AND CREATININE CLEARANCE

17 March 2023

34

1 reference

https://api.crossref.org/works/10.1016/0002-8703(70)90402-3

Plasma Volume Expansion Resulting from Interference with Adrenergic Function in Normal Man

17 March 2023

35

1 reference

https://api.crossref.org/works/10.1016/0002-8703(70)90402-3

PHARMACODYNAMIC EFFECTS OF ALPHA-METHYL DOPA IN HYPERTENSIVE SUBJECTS

17 March 2023

36

1 reference

https://api.crossref.org/works/10.1016/0002-8703(70)90402-3

The acute hemodynamic eeffects of alpha-methyldopa in man

17 March 2023

37

1 reference

https://api.crossref.org/works/10.1016/0002-8703(70)90402-3

THE ACUTE HEMODYNAMIC EFFECTS OF L-ALPHA METHYLDOPA

17 March 2023

38

1 reference

https://api.crossref.org/works/10.1016/0002-8703(70)90402-3

HAeMODYNAMIC STUDIES WITH METHYLDOPA: EFFECT ON CARDIAC OUTPUT AND RESPONSE TO PRESSOR AMINES

17 March 2023

40

1 reference

https://api.crossref.org/works/10.1016/0002-8703(70)90402-3

The effects of alpha-methyldopa on renal function in hypertensive patients

17 March 2023

43

1 reference

https://api.crossref.org/works/10.1016/0002-8703(70)90402-3

The Relative Efficacy of Guanethidine, Methyldopa and Pargyline as Antihypertensive Agents

17 March 2023

44

1 reference

https://api.crossref.org/works/10.1016/0002-8703(70)90402-3

17 March 2023

Identifiers

1 reference

16 September 2017

1 reference